Estrugenone en es it fr

Estrugenone Brand names, Estrugenone Analogs

Estrugenone Brand Names Mixture

  • Cimicifuga Plex (Caulophyllum Thalictroides + Cimicifuga Racemosa + Copper + Cotton Plant + Estrone + Histamine Dihydrochloride + Hypothalamus + Magnesium Phosphate Dibasic + Pituitary Whole + Platinum + Sepia Officinalis L + Thyroid)
  • Holis 98 (Dioscorea Vilosa + Estrone + Salvia + Saw Palmetto)

Estrugenone Chemical_Formula

C18H22O2

Estrugenone RX_link

No information avaliable

Estrugenone fda sheet

Estrugenone msds (material safety sheet)

Estrugenone MSDS

Estrugenone Synthesis Reference

G. Anner, K. Miescher, and Helv. Chem. Acta. 31, 2173(1948)

Estrugenone Molecular Weight

270.366 g/mol

Estrugenone Melting Point

254.5-256 oC

Estrugenone H2O Solubility

3 g/100mL

Estrugenone State

Solid

Estrugenone LogP

4.067

Estrugenone Dosage Forms

Vaginal cream; Vaginal suppository; Patch; Skin gel; Tablet; IM injectable suspension

Estrugenone Indication

For management of Menopausal and postmenopausal disorders

Estrugenone Pharmacology

Estrone, a synthetically prepared or naturally occurring steroidal estrogen obtained from pregnant equine urine, is the primary circulating estrogen after menopause. Estrone is naturally derived from the peripheral conversion of androstenedione by an aromatase enzyme found in adipose tissues and is converted to estradiol in peripheral tissues. Estropipate is piperazine-stabilized estrone sulfate. Estrone, and estropipate are used to treat abnormalities related to gonadotropin hormone dysfunction, vasomotor symptoms, atrophic vaginitis, and vulvar atrophy associated with menopause, and for the prevention of osteoporosis due to estrogen deficiency.

Estrugenone Absorption

43%

Estrugenone side effects and Toxicity

Symptoms of overdose include nausea and vomiting. Withdrawal bleeding may occur in females.

Estrugenone Patient Information

Estrugenone Organisms Affected

Humans and other mammals